Next Article in Journal
Circadian Rhythm and Alzheimer’s Disease
Next Article in Special Issue
Causes of Pulmonary Fibrosis in the Elderly
Previous Article in Journal
Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmonary Disease? What Do We Need to Add?

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis

Unit of Interstitial Lung Diseases, Pneumology Service, Hospital General Universitario, 46014 Valencia, Spain
Hospital Sant Francecs de Borja, Gandía, 46702 Valencia, Spain
Author to whom correspondence should be addressed.
Med. Sci. 2018, 6(2), 51;
Received: 23 May 2018 / Accepted: 11 June 2018 / Published: 14 June 2018
(This article belongs to the Special Issue Idiopathic Pulmonary Fibrosis)
Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias. With a median survival of 3–5 years following diagnosis, IPF is characterized by a progressive decline in lung function and quality of life in most patients. Prognostic factors recognized classically that influence mortality include functional, clinical and radiological parameters. However, in recent years, there has also been progress in the knowledge of genetic factors and biomarkers that may be useful in the prognostic evaluation of these patients. On the other hand, the monitoring of the disease throughout its evolution is key to improving the prognosis of the patients, as it allows for taking therapeutic measures based on this evolution, even early remission for lung transplantation. This article reviews the main prognostic factors of the disease, as well as the most useful way to monitor the disease follow-up. View Full-Text
Keywords: idiopathic pulmonary fibrosis; prognostic factors; monitoring; follow-up idiopathic pulmonary fibrosis; prognostic factors; monitoring; follow-up
MDPI and ACS Style

Fernández Fabrellas, E.; Peris Sánchez, R.; Sabater Abad, C.; Juan Samper, G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Med. Sci. 2018, 6, 51.

AMA Style

Fernández Fabrellas E, Peris Sánchez R, Sabater Abad C, Juan Samper G. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis. Medical Sciences. 2018; 6(2):51.

Chicago/Turabian Style

Fernández Fabrellas, Estrella; Peris Sánchez, Ricardo; Sabater Abad, Cristina; Juan Samper, Gustavo. 2018. "Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis" Med. Sci. 6, no. 2: 51.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop